Marianna Orlova1,2,3, Erwin Schurr1,2,3. 1. Program in Infectious Diseases and Immunity in Global Health, The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada. 2. McGill International TB Centre, McGill University, Montreal, Quebec, Canada. 3. Departments of Medicine and Human Genetics, McGill University, Montreal, Quebec, Canada.
Abstract
PURPOSE OF REVIEW: The study of the genetic basis of tuberculosis pathogenesis has benefited from powerful technological innovations, a more structured definition of latent and clinical manifestations of the disease, and the application of functional genomics approaches. This short review aims to summarize recent advances and to provide a link with results of previous human genetic studies of tuberculosis susceptibility. RECENT FINDINGS: Transcriptomics has been shown to be a useful tool to predict progression from latency to clinical disease while functional genomics has traced the molecular events that link pathogen-triggered gene expression and host genetics. Resistance to infection with Mycobacterium tuberculosis has been revealed to be strongly impacted by host genetics. Host genomics of clinical disease has been shown to be most powerful when focusing on carefully selected clinical entities and possibly by considering host pathogen combinations. SUMMARY: Future studies need to build on the latest molecular findings to define disease subtypes to successfully elucidate the human genetic component in tuberculosis pathogenesis.
PURPOSE OF REVIEW: The study of the genetic basis of tuberculosis pathogenesis has benefited from powerful technological innovations, a more structured definition of latent and clinical manifestations of the disease, and the application of functional genomics approaches. This short review aims to summarize recent advances and to provide a link with results of previous human genetic studies of tuberculosis susceptibility. RECENT FINDINGS: Transcriptomics has been shown to be a useful tool to predict progression from latency to clinical disease while functional genomics has traced the molecular events that link pathogen-triggered gene expression and host genetics. Resistance to infection with Mycobacterium tuberculosis has been revealed to be strongly impacted by host genetics. Host genomics of clinical disease has been shown to be most powerful when focusing on carefully selected clinical entities and possibly by considering host pathogen combinations. SUMMARY: Future studies need to build on the latest molecular findings to define disease subtypes to successfully elucidate the human genetic component in tuberculosis pathogenesis.
Entities:
Keywords:
functional genomics of tuberculosis; host genomics of tuberculosis; human genetics of infection; transcript biomarkers; tuberculosis
Authors: Alexandre Alcaïs; Lluis Quintana-Murci; David S Thaler; Erwin Schurr; Laurent Abel; Jean-Laurent Casanova Journal: Ann N Y Acad Sci Date: 2010-11-22 Impact factor: 5.691
Authors: Suneil Malik; Laurent Abel; Heather Tooker; Audrey Poon; Leah Simkin; Manon Girard; Gerald J Adams; Jeffrey R Starke; Kimberly C Smith; Edward A Graviss; James M Musser; Erwin Schurr Journal: Proc Natl Acad Sci U S A Date: 2005-08-15 Impact factor: 11.205
Authors: Aurelie Cobat; Caroline J Gallant; Leah Simkin; Gillian F Black; Kim Stanley; Jane Hughes; T Mark Doherty; Willem A Hanekom; Brian Eley; Nulda Beyers; Jean-Philippe Jaïs; Paul van Helden; Laurent Abel; Eileen G Hoal; Alexandre Alcaïs; Erwin Schurr Journal: J Infect Dis Date: 2010-01-01 Impact factor: 5.226
Authors: Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra Journal: Nature Date: 2010-08-19 Impact factor: 49.962
Authors: Gardar Sveinbjornsson; Daniel F Gudbjartsson; Bjarni V Halldorsson; Karl G Kristinsson; Magnus Gottfredsson; Jeffrey C Barrett; Larus J Gudmundsson; Kai Blondal; Arnaldur Gylfason; Sigurjon Axel Gudjonsson; Hafdis T Helgadottir; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Ari Karason; Ljiljana Bulat Kardum; Jelena Knežević; Helgi Kristjansson; Mar Kristjansson; Arthur Love; Yang Luo; Olafur T Magnusson; Patrick Sulem; Augustine Kong; Gisli Masson; Unnur Thorsteinsdottir; Zlatko Dembic; Sergey Nejentsev; Thorsteinn Blondal; Ingileif Jonsdottir; Kari Stefansson Journal: Nat Genet Date: 2016-02-01 Impact factor: 38.330
Authors: Michael L McHenry; Jacquelaine Bartlett; Robert P Igo; Eddie M Wampande; Penelope Benchek; Harriet Mayanja-Kizza; Kyle Fluegge; Noemi B Hall; Sebastien Gagneux; Sarah A Tishkoff; Christian Wejse; Giorgio Sirugo; W Henry Boom; Moses Joloba; Scott M Williams; Catherine M Stein Journal: PLoS Genet Date: 2020-04-30 Impact factor: 5.917
Authors: Marlo Möller; Craig J Kinnear; Marianna Orlova; Elouise E Kroon; Paul D van Helden; Erwin Schurr; Eileen G Hoal Journal: Front Immunol Date: 2018-09-27 Impact factor: 7.561
Authors: Michael L McHenry; Eddie M Wampande; Moses L Joloba; LaShaunda L Malone; Harriet Mayanja-Kizza; William S Bush; W Henry Boom; Scott M Williams; Catherine M Stein Journal: Pathogens Date: 2021-11-15
Authors: Sherry L Kurtz; Amy P Rossi; Gillian L Beamer; Dan M Gatti; Igor Kramnik; Karen L Elkins Journal: mSphere Date: 2020-04-15 Impact factor: 4.389